Staufenbiel M - Search Results

1

Altered circadian locomotor activity in APP23 mice: a model for BPSD disturbances.

Vloeberghs E, Van Dam D, Engelborghs S, Nagels G, Staufenbiel M, De Deyn PP. Vloeberghs E, et al. Among authors: staufenbiel m. Eur J Neurosci. 2004 Nov;20(10):2757-66. doi: 10.1111/j.1460-9568.2004.03755.x. Eur J Neurosci. 2004. PMID: 15548219

2

Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis.

Boncristiano S, Calhoun ME, Kelly PH, Pfeifer M, Bondolfi L, Stalder M, Phinney AL, Abramowski D, Sturchler-Pierrat C, Enz A, Sommer B, Staufenbiel M, Jucker M. Boncristiano S, et al. Among authors: staufenbiel m. J Neurosci. 2002 Apr 15;22(8):3234-43. doi: 10.1523/JNEUROSCI.22-08-03234.2002. J Neurosci. 2002. PMID: 11943824 Free PMC article.

3

Age-dependent cognitive decline in the APP23 model precedes amyloid deposition.

Van Dam D, D'Hooge R, Staufenbiel M, Van Ginneken C, Van Meir F, De Deyn PP. Van Dam D, et al. Among authors: staufenbiel m. Eur J Neurosci. 2003 Jan;17(2):388-96. doi: 10.1046/j.1460-9568.2003.02444.x. Eur J Neurosci. 2003. PMID: 12542676

4

Age-dependent impairment of somatosensory response in the amyloid precursor protein 23 transgenic mouse model of Alzheimer's disease.

Mueggler T, Baumann D, Rausch M, Staufenbiel M, Rudin M. Mueggler T, et al. Among authors: staufenbiel m. J Neurosci. 2003 Sep 10;23(23):8231-6. doi: 10.1523/JNEUROSCI.23-23-08231.2003. J Neurosci. 2003. PMID: 12967984 Free PMC article.

5

Age-dependent cerebrovascular abnormalities and blood flow disturbances in APP23 mice modeling Alzheimer's disease.

Beckmann N, Schuler A, Mueggler T, Meyer EP, Wiederhold KH, Staufenbiel M, Krucker T. Beckmann N, et al. Among authors: staufenbiel m. J Neurosci. 2003 Sep 17;23(24):8453-9. doi: 10.1523/JNEUROSCI.23-24-08453.2003. J Neurosci. 2003. PMID: 13679413 Free PMC article.

6

Restricted diffusion in the brain of transgenic mice with cerebral amyloidosis.

Mueggler T, Meyer-Luehmann M, Rausch M, Staufenbiel M, Jucker M, Rudin M. Mueggler T, et al. Among authors: staufenbiel m. Eur J Neurosci. 2004 Aug;20(3):811-7. doi: 10.1111/j.1460-9568.2004.03534.x. Eur J Neurosci. 2004. PMID: 15255991

7

Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model.

Van Dam D, Abramowski D, Staufenbiel M, De Deyn PP. Van Dam D, et al. Among authors: staufenbiel m. Psychopharmacology (Berl). 2005 Jun;180(1):177-90. doi: 10.1007/s00213-004-2132-z. Epub 2005 Jan 15. Psychopharmacology (Berl). 2005. PMID: 15654502

8

Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.

Van Dam D, Marescau B, Engelborghs S, Cremers T, Mulder J, Staufenbiel M, De Deyn PP. Van Dam D, et al. Among authors: staufenbiel m. Neurochem Int. 2005 Apr;46(5):409-22. doi: 10.1016/j.neuint.2004.11.005. Epub 2005 Jan 17. Neurochem Int. 2005. PMID: 15737439

9

APP23 mice as a model of Alzheimer's disease: an example of a transgenic approach to modeling a CNS disorder.

Van Dam D, Vloeberghs E, Abramowski D, Staufenbiel M, De Deyn PP. Van Dam D, et al. Among authors: staufenbiel m. CNS Spectr. 2005 Mar;10(3):207-22. doi: 10.1017/s1092852900010051. CNS Spectr. 2005. PMID: 15744222 Review.

10

APP23 mice display working memory impairment in the plus-shaped water maze.

Vloeberghs E, Van Dam D, D'Hooge R, Staufenbiel M, De Deyn PP. Vloeberghs E, et al. Among authors: staufenbiel m. Neurosci Lett. 2006 Oct 16;407(1):6-10. doi: 10.1016/j.neulet.2006.07.060. Epub 2006 Sep 7. Neurosci Lett. 2006. PMID: 16959424

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

215 results

Search Page

Filters